期刊文献+

含黄素单氧化酶3(FMO3)结构、功能及其基因多态性的研究进展 被引量:2

Advance in flavin-containing monooxygenase 3(FMO3):structure/function and genetic polymorphisms
下载PDF
导出
摘要 含黄素单氧化酶3(flavin-containing monooxygenase 3,FMO3)是一种重要的肝微粒体酶,参与体内大量药物、外源性物质和其他一些化学物质的氧化代谢。FMO3基因存在多态性,其中的一些基因突变可以引起酶活性改变,从而改变底物的代谢。体内外许多研究证明FMO3有明显的个体差异和种族差异,因此,FMO3的遗传变异在药物研制和个体化治疗中将起着重要的作用。该文就FMO3结构、功能及其基因多态性与药物代谢和疾病的关系进行综述。 Flavin-containing monooxygenase 3 ( FMO3 ) is an important hepatic microsomal enzyme that oxidizes a number of drugs, xenobiotics and other chemicals. Many variants in the gene encoding FMO3 have been identified, some of which result in altered enzymatic activity, consenquently, altered substrate metabolism. Studies also implicate individual and ethnic differences in FMO3. Thus ,it is anticipated that knowledge regarding functionally-relevant FMO3 genetic variability will become increasingly important for drug development and patient therapeutic choices.
出处 《中国药理学通报》 CAS CSCD 北大核心 2008年第10期1261-1264,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No30572226)
关键词 FMO3 基因多态性 药物代谢 个体化治疗 flavin-containing monooxygenase 3 genetic polymorphism drug metabolism individual treatment
  • 相关文献

参考文献26

  • 1Phillips I R, Dolphin C T, Clair P, et al. The molecular hiology of the flavin-containing nlonooxygenases of man[ J]. Chem Biol Interact, 1995,96( 1 ) : 17 - 32.
  • 2Koukouritaki S B, Simpson P, Yeung C K, et al. Human hepatic flavin-eontaining monooxygenases 1 ( FMOI ) and 3 ( FMO3 ) developmental expression [J].Pediatr Res,2002,51 ( 2 ) :236 - 43.
  • 3A1-Waiz M, Ayesh R, Mitchell S C, et al. A genetic polymorohism of the N-oxidation of trimethylamine in humans [ J ]. Clin Pbarmacol Ther,1987,42 ( 5 ) :588 - 94.
  • 4Chung W G, Park C S, Roh H K. el al. Oxidation of ranilidine by isozymes of flavin-containing monooxygenase and cytochrome P450 [J]. Jpn J Pbarmacol,2000,84 ( 2 ) : 213 - 20.
  • 5Lawton M P,Gasser R,Tynes R E,et al. The flavin-containing monooxygenase enzymes expressed in rabbit liver and lung are produets of related but distinctly different genes [J]. J Biol Chem, 1990,265(10) :5855 -61.
  • 6Massev V. Activation of molecular oxygen by flavins and flavoproreins [J].J Biol Chem, 1994,269 ( 36 ) : 22459 - 62.
  • 7Mitchell S C,Smith R L. Trimethylaminuria: the fish malodor syndrome[ J]. Drug Metab Dispos,2001,29(4 Pt 2) :517 -21.
  • 8Park C S, Chung W G, Kang J H, et al. Phenotyping of flavin-conraining monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population[ J ]. Pharmacogenetics, 1999,9 (2) :155 -64.
  • 9Lang D H, Rettie A E. In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO) : metabolism of benzydamine and caffeine by FMO and P450 isoforms [ J ]. Br J Clin Pharmacol,2000,50(4) :311 -4.
  • 10Kang J H,Chung W G, Lee K H, et al. Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FMO3 gene mutations in a Korean population[ J]. Pharmacogenetics ,2000,10( 1 ) : 67 - 78.

同被引文献13

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部